Firm at a glance
Clessidra is a platform private equity firm headquartered in Milano, Italy, per its own website [S1].
What they buy
Based on publicly reported transactions, Clessidra appears to pursue platform investments across Italian mid-market businesses in consumer, healthcare, and food sectors [S2]. Recent acquisitions include companies in confectionery manufacturing, healthcare services, and food production, suggesting a focus on established Italian businesses with potential for consolidation [S2]. The firm also operates a private debt strategy alongside its equity investments [S2].
Portfolio
Clessidra’s recent platform acquisitions include:
* **Gruppo Sopran Ciodue** (acquired April 2026) [S2]
* **Laurieri** (acquired November 2025) [S2]
* **Health Italia** (acquired December 2025) [S2]
* **D.I.MAR. S.r.l. (Sapore di Mare)** (acquired May 2026) [S2]
The firm has also executed add-on acquisitions, including **Italgum Caramelle** as an add-on to its Candy Factory platform (December 2025) [S2].
Recent activity (last 24 months)
* May 2026: Acquired D.I.MAR. S.r.l. (Sapore di Mare) [S2]
* April 2026: Acquired Gruppo Sopran Ciodue [S2]
* March 2026: Closed Clessidra Private Debt II fund [S2]
* December 2025: Exited MGM [S2]
* December 2025: Acquired Health Italia [S2]
* December 2025: Acquired Italgum Caramelle as add-on to Candy Factory [S2]
* November 2025: Acquired Laurieri [S2]
How this firm fits a seller
Clessidra appears to target Italian mid-market businesses with established market positions, based on its recent transaction history [S2]. The firm demonstrates willingness to execute both platform acquisitions and add-on transactions, as evidenced by the Italgum Caramelle bolt-on in December 2025 [S2]. For sellers in consumer goods, healthcare services, or food manufacturing sectors operating in Italy, Clessidra represents a domestic buyer with active deployment activity. The firm’s exit of MGM in December 2025 suggests an active portfolio management approach [S2].
Sources
[S1] https://clessidragroup.it (as of 2025-01-15)
[S2] https://clessidragroup.it/news/ (as of 2025-01-15)
Frequently asked questions
Does Clessidra Private Equity buy healthcare businesses?
Yes, Clessidra has demonstrated interest in healthcare services, having acquired Health Italia in December 2025 [S2]. This transaction suggests the firm pursues opportunities in the Italian healthcare sector, though the scope and specific subsectors remain publicly undefined.
What companies has Clessidra Private Equity acquired recently?
Recent acquisitions include D.I.MAR. S.r.l. (Sapore di Mare) in May 2026, Gruppo Sopran Ciodue in April 2026, and Health Italia in December 2025 [S2]. The firm also added Italgum Caramelle to its Candy Factory platform in December 2025 [S2].
Where is Clessidra Private Equity based and how big is the firm?
Clessidra is based in Milano, Italy, with offices at Piazza San Babila [S1]. The firm’s assets under management and team size are not publicly disclosed in available sources as of January 2025.
Is Clessidra Private Equity still actively acquiring?
Yes, Clessidra appears actively acquiring based on its recent transaction pace. The firm completed acquisitions as recently as May 2026 with D.I.MAR. S.r.l. and April 2026 with Gruppo Sopran Ciodue [S2], indicating ongoing deployment activity.
This profile is maintained by CT Acquisitions as an independent third-party reference. CT Acquisitions is not affiliated with, endorsed by, or a representative of the firm profiled. All facts sourced from publicly available materials as of the dates cited.